Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November

South Africa News News

Pfizer Could Apply for Emergency Use of Covid-19 Vaccine by Late November
South Africa Latest News,South Africa Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 63%

Drug giant Pfizer said it could be ready to apply for emergency-use authorization of its Covid-19 vaccine by late November, assuming it receives positive efficacy and safety data from late-stage human trials

Pfizer Inc. said it could be ready to apply for emergency-use authorization of its Covid-19 vaccine by late November, assuming it receives positive efficacy and safety data from late-stage human trials now under way.

The drug giant, which is developing its vaccine candidate with German partner BioNTech SE, said it continues to expect to have data on the vaccine’s effectiveness—whether it protects at least a majority of vaccinated people from the disease—later this month. It then expects to have data on the drug’s safety by...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer, BioNTech Race to Meet Global Covid-19 Vaccine NeedsPfizer, BioNTech Race to Meet Global Covid-19 Vaccine NeedsThe chief executive of the German company partnering with Pfizer in its coronavirus vaccine effort said the two are racing to increase production to meet the world’s needs, assuming the shot wins a regulatory green light
Read more »

The Latest Developments On COVID-19 Treatments And VaccinesThe Latest Developments On COVID-19 Treatments And VaccinesPfizer received FDA approval to enroll adolescents in its COVID-19 vaccine trial. Experts say it's an important step aimed at determining whether a vaccine could be safe and effective in children.
Read more »

Countries turn to rapid antigen tests to contain second wave of COVID-19Countries turn to rapid antigen tests to contain second wave of COVID-19Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those infected quickly.
Read more »

COVID-19 increases risks for cancer patients; common cold antibodies no help vs coronavirusCOVID-19 increases risks for cancer patients; common cold antibodies no help vs coronavirusThe following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Read more »

Mexico's Covid-19 death toll nears 85,000 – latest updatesMexico's Covid-19 death toll nears 85,000 – latest updatesHealth care professionals account for about 15% of all Covid-19 cases in Mexico and 18% of the death toll. Here are other updates 🇰🇷 South Korea reports 110 cases 🇨🇳 Mainland China reports 11 new cases 🇧🇷 Brazil registers 749 coronavirus deaths Read more:
Read more »



Render Time: 2025-04-24 20:57:16